ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
EV to Sales HistoryFair Value
Percentile Rank71
3Y CAGR+20.6%
5Y CAGR+27.7%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
+20.6%/yr
vs -14.9%/yr prior
5Y CAGR
+27.7%/yr
Recent deceleration
Acceleration
+35.5pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
3.4x
Strong expansion
Streak
1 yr
Consecutive declineFair Value
PeriodValueYoY Change
20254.47-33.2%
20246.69+138.0%
20232.81+10.2%
20222.55-88.8%
202122.81+1633.7%
20201.32-76.1%
20195.50+12.8%
20184.87+19.5%
20174.07+14.6%
20163.56-